The Latest

Early View Perspective
June 2026

Missed Opportunities: Using Medicaid Section 1115 Projects to Improve the Health of Medicaid and Medicare Beneficiaries

By:  Leighton Ku

Medicaid Section 1115 demonstration projects are widely used to test innovative policies but are subject to “budget neutrality” limits so that federal expenditures do not exceed what the federal government would have spent if the project was not adopted. More

Early View Perspective
June 2026

Racial Equity Impact Assessments as Tools for Advancing Population Health and Equity in Local Policy

By:  Kellee White Whilby Makeda Walelo Heron Bondoc

Racial equity impact assessments (REIAs) are used by local governments to integrate equity considerations into policymaking and decision-making processes by evaluating potential impacts of proposed legislation before enactment. More

Open Access
Early View Perspective
June 2026

Federal Nutrition Assistance Programs 2021 to 2025: Policy Expansion and Contraction

By:  Sara N. Bleich Hilary Seligman

From 2021 to 2025, federal nutrition assistance policy in the United States shifted rapidly from expansion to contraction, with major implications for food insecurity, diet quality, and chronic disease risk. More

Early View Perspective
May 2026

The Carceral Shadow: Criminal Justice as a Determinant of Health and Challenges for Policymakers

By:  Rashawn Ray Keon Gilbert

The United States incarcerates more people per capita than any peer nation, and its criminal justice system disproportionately impacts Black, Indigenous, and other communities of color. More

Open Access
Early View Original Scholarship
May 2026

Trust Through Others’ Eyes: An Experiment on How Vicarious Health Care Experiences Shape System Trust

By:  Silvia Cannas Maria Cucciniello

Trust in the US health care system has declined substantially in recent years, threatening patient engagement, care outcomes, and health policy effectiveness. More

Open Access
Early View Original Scholarship
May 2026

Stretching Scarce Authorizing Legislation as Far as Possible: A Legislative History of the 340B Drug Pricing Program

By:  Sayeh Nikpay Mikayla Reinke Nicole Quinones

The 1992 340B Drug Pricing Program (“340B”) started as a narrowly focused program aimed at Public Health Service Act–funded clinics and public hospitals. Today 340B includes two-thirds of all nonprofit hospitals in the United States and accounts for more than $80 billion in discounted drug purchases. More

Open Access

View All Articles

Opinions

Lawrence O. Gostin
June, 2026

Mother Nature is Screaming: Two Viral Spillovers – Ebola and Hantavirus Emergencies – Expose our Vulnerabilities

When I arrived in Geneva for the World Health Assembly in late May, the World Health Organization (WHO) was scrambling to contain two extremely…  More
Lawrence O. Gostin
May, 2026

The Hondius Outbreak Shows What Happens When the CDC Retreats from the World

For more than three decades, I have worked alongside the Centers for Disease Control and Prevention (CDC) during many of the world’s most consequential biological threats—from the containment of SARS-CoV-1 and the West African Ebola epidemic to the global responses to Zika and COVID-19.  More
Heidi L. Allen
April, 2026

A Mental Health Lifeline: How Psychedelics Could Offer Millions of Americans Hope

For patients who have exhausted evidence-based therapies—including selective serotonin reuptake inhibitors (SSRIs), atypical antipsychotics, and cognitive behavioral interventions—access to experimental treatments should be no less available than it is for individuals with refractory cancer or Parkinson’s disease.  More
David Rosner
April, 2026

Manipulating Science, Manipulating Us

Four decades ago, I and Gerald Markowitz published an article in the American Journal of Public Health that attracted a fair amount of attention. The article was about the history of the introduction of tetraethyl lead into gasoline in the 1920s.  The article detailed the controversy over putting lead, even then a known industrial poison and neurotoxin, into the gasoline that was powering the new automobile, particularly those that were produced by the General Motors Company.  More
Dalton Conley
April, 2026

Money for Nothing? Universal Basic Income as Health Policy

To make a point, the Marxist sociologist Erik Olin Wright (1997) once borrowed a character from the 1960s comic strip Lil’ Abner: a big blobby…  More
Joshua M. Sharfstein
April, 2026

Learning to Love the Data Quality Act

At the very end of the Clinton Administration, Republican Congresswoman JoAnne Emerson inserted a two-paragraph provision into the 2001 Treasury and General Government Appropriations Act. These paragraphs would become known as the Data Quality Act (as well as the Information Quality Act) and its passage represented a major victory for industries – including the tobacco and chemical industries – regulated by the federal government.   More

View All Opinions

Special Issue

Read the articles

Disease Burden, Mortality, and Life Expectancy in the United States: What Can State Policymakers Do to Meet the Challenges?

In 2026, The Milbank Quarterly is publishing a special issue with articles that address epidemiologic trends and challenges, health care issues and state-level innovations, and public health infrastructure and governmental issues. The articles will be published over the next six months.

For Authors

Information, instructions for authors, publication policies, and additional resources for authors interested in submitting manuscripts to The Milbank Quarterly.

Learn More

About The Milbank Quarterly

Continuously published since 1923, The Milbank Quarterly features peer-reviewed original research, policy review, and analysis from academics, clinicians, and policymakers.

Editor

Alan B. Cohen

Publisher

Debra Lubar

Managing Editor

Tara Strome

2-year Impact Factor: 6.6
Journal Citation Reports® 2022 Rankings: 3/87 (Health Policy & Services); 8/105 (Health Care Sciences & Services)
5-year Impact Factor: 8.964